Dr Mohammed Alshawsh is currently working as Associate Professor at Department of Pharmacology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia. He obtained his PhD from Faculty of Medicine, University of Malaya in 2012. After his one-year postdoc at University of Malaya, he joined Department of Pharmacology, University of Malaya in 2013. Since then he has been doing preclinical research in the area of metabolic syndrome, cancer and safety pharmacology. His current field of research interest mainly focuses on pharmacological investigations of flavonoids, other polyphenol phytoconstituents and natural products for the treatment of colorectal cancer, obesity, diabetes, and fatty liver diseases using in vivo (animal models) and in vitro (cell culture) studies and investigating the gene expression profiling to unravel the underlying molecular mechanisms. He is also doing safety and toxicology studies in particular acute, subacute, and chronic toxicities, genotoxicity, teratogenicity and postnatal developmental toxicity. Dr. Alshawsh is a scientist member of Faculty of Medicine-Institutional Animal Care and Use Committee (FOM-IACUC)-University Malaya, Italo-Latin American Society of Ethnomedicine, Laboratory Animal Science Association of Malaysia (LASAM), and Malaysian Society of Pharmacology and Physiology. He serves as Associate Editor for the BMC Complementary and Alternative Medicine Journal. He is also an editorial board member and a reviewer for several international journals. He supervised 6 PhD students to completion; currently, he is supervising 4 PhD students and 3 Master students. He has published over 40 papers in peer-reviewed journals with an h-index of 12 and has given over 20 invited and plenary lectures at international conferences. He has obtained several research grants, such as UMRG, BKS, PPP and FRGS.